Marcus Järås
21 – 30 of 44
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS
(
- Contribution to journal › Article
- 2014
-
Mark
Modeling chronic myeloid leukemia in immunodeficient mice reveals expansion of aberrant mast cells and accumulation of pre-B cells.
(
- Contribution to journal › Article
-
Mark
Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia
(
- Contribution to journal › Article
-
Mark
Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS
(
- Contribution to journal › Article
- 2013
-
Mark
SOCS2 is dispensable for BCR/ABL1-induced chronic myeloid leukemia-like disease and for normal hematopoietic stem cell function.
(
- Contribution to journal › Article
-
Mark
Selective killing of candidate AML stem cells by antibody targeting of IL1RAP.
(
- Contribution to journal › Article
-
Mark
Niche-based screening identifies small-molecule inhibitors of leukemia stem cells
(
- Contribution to journal › Article
-
Mark
InVivo RNAi Screening Identifies a Leukemia-Specific Dependence on Integrin Beta 3 Signaling
(
- Contribution to journal › Article
- 2011
-
Mark
Power Cut : Inhibiting Mitochondrial Translation to Target Leukemia
(
- Contribution to journal › Article
- 2010
-
Mark
Modeling the human 8p11-myeloproliferative syndrome in immunodeficient mice
(
- Contribution to journal › Article